-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, J6wfR/zDv2R8iXAKYZ2oiMCa0YaAKC0+Qut5Luw6j/1PnQm5lrEVFFGtSsejCNAw 1ZIdtYX6CdePzRDCkNXdFQ== 0000902664-08-002321.txt : 20080702 0000902664-08-002321.hdr.sgml : 20080702 20080702165923 ACCESSION NUMBER: 0000902664-08-002321 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080702 DATE AS OF CHANGE: 20080702 GROUP MEMBERS: CR INTRINSIC INVESTMENTS, LLC GROUP MEMBERS: CR INTRINSIC INVESTORS, LLC GROUP MEMBERS: S.A.C. CAPITAL ADVISORS, LLC GROUP MEMBERS: S.A.C. CAPITAL ASSOCIATES, LLC GROUP MEMBERS: S.A.C. CAPITAL MANAGEMENT, LLC GROUP MEMBERS: S.A.C. MERIDIAN FUND, LLC GROUP MEMBERS: S.A.C. MULTIQUANT FUND, LLC GROUP MEMBERS: S.A.C. SELECT FUND, LLC GROUP MEMBERS: STEVEN A. COHEN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BARRIER THERAPEUTICS INC CENTRAL INDEX KEY: 0001173657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223828030 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-79875 FILM NUMBER: 08935200 BUSINESS ADDRESS: STREET 1: 600 COLLEGE ROAD EAST STREET 2: SUITE 3200 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6099451200 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SAC CAPITAL ADVISORS LLC CENTRAL INDEX KEY: 0001018103 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 2036142000 MAIL ADDRESS: STREET 1: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 SC 13D 1 p08-1136sc13d.txt BARRIER THERAPEUTICS, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* Barrier Therapeutics, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $0.0001 Par Value Per Share - -------------------------------------------------------------------------------- (Title of Class of Securities) 06850R108 - -------------------------------------------------------------------------------- (CUSIP Number) Peter A. Nussbaum, Esq. CR Intrinsic Investors, LLC 72 Cummings Point Road Stamford, CT 06902 (203) 890-2000 with a copy to: Marc Weingarten, Esq. David Rosewater, Esq. Schulte Roth & Zabel LLP 919 Third Avenue New York, New York 10022 (212) 756-2000 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) June 23, 2008 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: [X] NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13D - ------------------------- ----------------------- CUSIP NO. 06850R108 PAGE 2 OF 14 PAGES - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON S.A.C. Capital Advisors, LLC - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] ------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS AF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 ------------------------------------------------------- NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY 850,200 OWNED BY ------------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH 0 ------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 850,200 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 850,200 - -------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.4% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) 00 - -------------------------------------------------------------------------------- SCHEDULE 13D - ------------------------- ----------------------- CUSIP NO. 06850R108 PAGE 3 OF 14 PAGES - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON S.A.C. Capital Management, LLC - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS AF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 ------------------------------------------------------- NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY 850,200 OWNED BY ------------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH 0 ------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 850,200 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 850,200 - -------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.4% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) 00 - -------------------------------------------------------------------------------- SCHEDULE 13D - ------------------------- ----------------------- CUSIP NO. 06850R108 PAGE 4 OF 14 PAGES - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON CR Intrinsic Investors, LLC - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS AF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 ------------------------------------------------------- NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY 1,970,000 OWNED BY ------------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH 0 ------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 1,970,000 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,970,000 - -------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.6% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) 00 - -------------------------------------------------------------------------------- SCHEDULE 13D - ------------------------- ----------------------- CUSIP NO. 06850R108 PAGE 5 OF 14 PAGES - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON CR Intrinsic Investments, LLC - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS AF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Anguilla, British West Indies - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 ------------------------------------------------------- NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY 1,970,000 OWNED BY ------------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH 0 ------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 1,970,000 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,970,000 - -------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.6% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) 00 - -------------------------------------------------------------------------------- SCHEDULE 13D - ------------------------- ----------------------- CUSIP NO. 06850R108 PAGE 6 OF 14 PAGES - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Steven A. Cohen - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS AF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 ------------------------------------------------------- NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY 2,820,200 OWNED BY ------------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH 0 ------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 2,820,200 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,820,200 - -------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 8.0% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - -------------------------------------------------------------------------------- SCHEDULE 13D - ------------------------- ----------------------- CUSIP NO. 06850R108 PAGE 7 OF 14 PAGES - -------------------------------------------------------------------------------- ITEM 1. SECURITY AND THE ISSUER This Schedule 13D (the "Schedule 13D") relates to shares of common stock, par value $0.0001 per share, of Barrier Therapeutics, Inc., a Delaware corporation (the "Issuer"). The principal executive office of the Issuer is located at 600 College Road East, Suite 3200, Princeton, NJ, 08540. This Schedule 13D supercedes the Schedule 13G previously filed by the Reporting Persons (as defined below) with respect to the Common Stock on May 16, 2008. ITEM 2. IDENTITY AND BACKGROUND (a) This statement is filed by: (i) S.A.C. Capital Advisors, LLC ("SAC Capital Advisors") with respect to shares of Common Stock directly beneficially owned by S.A.C. Capital Associates, LLC ("SAC Associates") and S.A.C. MultiQuant Fund, LLC ("SAC MultiQuant"); (ii) S.A.C. Capital Management, LLC ("SAC Capital Management") with respect to shares of Common Stock directly beneficially owned by SAC Associates and SAC MultiQuant; (iii) CR Intrinsic Investors, LLC ("CR Intrinsic Investors") with respect to shares of Common Stock directly beneficially owned by CR Intrinsic Investments, LLC ("CR Intrinsic Investments"); (iv) CR Intrinsic Investments, with respect to shares of Common Stock directly beneficially owned by it; and (v) Steven A. Cohen with respect to shares of Common Stock beneficially owned by SAC Capital Advisors, SAC Capital Management, SAC Associates, CR Instrinsic Investors, and CR Intrinsic Investments. SAC Capital Advisors, SAC Capital Management, CR Intrinsic Investors, CR Intrinsic Investments and Mr. Cohen (collectively, the "Reporting Persons") expressly disclaim beneficial ownership of securities directly beneficially owned by any person or entity other than, to the extent of any pecuniary interest therein, the various accounts under the Reporting Persons' management and control. (b) The address of the principal business office of (i) SAC Capital Advisors, CR Intrinsic Investors and Mr. Cohen is 72 Cummings Point Road, Stamford, Connecticut 06902, (ii) SAC Capital Management is 540 Madison Avenue, New York, New York 10022, and (iii) CR Intrinsic Investments is Box 174, Mitchell House, the Valley, Anguilla, British West Indies. (c) The principal business of each of SAC Capital Advisors and SAC Capital Management is to serve as investment manager to a variety of private investment funds, including SAC Associates and SAC MultiQuant, and to control the investing and trading in securities by these private investment funds. The principal business of CR Intrinsic Investors is to serve as investment manager to CR Intrinsic Investments, and to control the investing and trading in securities by this private investment fund. SCHEDULE 13D - ------------------------- ----------------------- CUSIP NO. 06850R108 PAGE 8 OF 14 PAGES - ------------------------- ------------------------ The principal business of CR Intrinsic Investments is to invest in securities. The principal business of Mr. Cohen is to serve as a principal of SAC Capital Advisors, SAC Capital Management, CR Intrinsic Investors, and of certain other affiliated entities. (d) None of the Reporting Persons has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) None of the Reporting Persons has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) SAC Capital Advisors, SAC Capital Management and CR Intrinsic Investors are Delaware limited liability companies. CR Intrinsic Investments is an Anguillan limited liability company. Mr. Cohen is a United States citizen. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. The Reporting Persons expended an aggregate of approximately $6,869,671 of working capital to purchase the 2,820,200 shares of Common Stock. Such transactions were effected in open market purchases and acquired in the ordinary course of business and are held by SAC Associates, SAC MultiQuant and CR Intrinsic Investments in commingled margin accounts maintained at Morgan Stanley & Co. and Goldman Sachs & Co., which may extend margin credit to the Reporting Persons as and when required to open or carry positions in the margin account, subject to applicable federal margin regulations, stock exchange rules and credit policies. In such instances, the positions held in the margin account are pledged as collateral security for the repayment of debit balances in the account. The margin account may from time to time have debit balances. Since other securities are held in the margin account, it is not possible to determine the amounts, if any, of margin used to purchase the shares of Common Stock reported herein. ITEM 4. PURPOSE OF TRANSACTION. The Reporting Persons acquired the Common Stock subject to this Schedule 13D for investment purposes, in the ordinary course of business, and not with the purpose or intent of changing or influencing the control of the Issuer and without any agreement with any third party to act together for the purpose of acquiring, holding, voting or disposing of equity securities of the Issuer. On June 23, 2008, Stiefel Laboratories, Inc. filed a tender offer statement with the Securities and Exchange Commission stating that the Issuer and Stiefel Laboratories, Inc. had entered into a definitive merger agreement. SCHEDULE 13D - ------------------------- ----------------------- CUSIP NO. 06850R108 PAGE 9 OF 14 PAGES - ------------------------- ------------------------ Except as set forth herein or as would occur upon completion of any of the actions discussed herein, including in any Exhibits hereto, the Reporting Persons have no present plan or proposal that would relate to or result in any of the matters set forth in subparagraphs (a)-(j) of Item 4 of Schedule 13D. The Reporting Persons intend to review their investment in the Issuer on a continuing basis and may engage in discussions with management, the board of directors, other shareholders of the Issuer and other relevant parties concerning the business, operations, management, strategy and future plans of the Issuer. Depending on various factors including, without limitation, the status of the announced aquisition, the Issuer's financial position and strategic direction, actions taken by the board of directors, price levels of the Common Stock, other investment opportunities available to the Reporting Persons, conditions in the securities market and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, purchasing additional shares of Common Stock or selling some or all of their Common Stock, engaging in short selling of or any hedging or similar transactions with respect to the Common Stock and/or otherwise changing their intention with respect to any and all matters referred to in Item 4 of Schedule 13D. Except as set forth herein, or as would occur upon completion of any of the matters discussed herein, the Reporting Persons have no present plan or proposal that would relate to or result in any of the matters set forth in subparagraphs (a)-(j) of Item 4 of Schedule 13D. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a) As of the close of business on July 1, 2008, the Reporting Persons beneficially own an aggregate of 2,820,200 shares of Common Stock, inclusive of 200 long calls, representing approximately 8.0% of the shares of Common Stock outstanding. The percentages used herein are based upon the 35,169,441 shares of Common Stock reported to be outstanding as of May 7, 2008 by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 9, 2008. SAC Capital Advisors, SAC Capital Management, CR Intrinsic Investors and Mr. Cohen own directly no shares of Common Stock. Pursuant to investment management agreements, each of SAC Capital Advisors and SAC Capital Management hold all investment and voting power with respect to securities held by SAC Associates and SAC MultiQuant. Pursuant to an investment management agreement, CR Intrinsic Investors holds investment and voting power with respect to securities held by CR Intrinsic Investments. Mr. Cohen controls each of SAC Capital Advisors, SAC Capital Management and CR Intrinsic Investors. By reason of the provisions of Rule 13d-3 of the Act, as amended, each of (i) SAC Capital Advisors, SAC Capital Management and Mr. Cohen may be deemed to own beneficially 850,200 shares of Common Stock (constituting approximately 2.4% of the shares of Common Stock outstanding) and (ii) CR Intrinsic Investors and Mr. Cohen may be deemed to own beneficially 1,970,000 shares of Common Stock (constituting approximately 5.6% of the shares of Common Stock outstanding). (b) None of the Reporting Persons has sole power to vote or direct the vote or sole power to dispose or direct the disposition of shares of Common Stock. (i) SAC Capital Advisors has shared power to vote or direct the vote and shared power to dispose or direct the disposition of 850,200 shares of Common Stock, constituting approximately 2.4% of such class of securities; - ------------------------- ----------------------- CUSIP NO. 06850R108 PAGE 10 OF 14 PAGES - ------------------------- ------------------------ (ii) SAC Capital Management has shared power to vote or direct the vote and shared power to dispose or direct the disposition of 850,200 shares of Common Stock, constituting approximately 2.4% of such class of securities; (iii) CR Intrinsic Investors has shared power to vote or direct the vote and shared power to dispose or direct the disposition of 1,970,000 shares of Common Stock, constituting approximately 5.6% of such class of securities; (iv) CR Intrinsic Investments has shared power to vote or direct the vote and shared power to dispose or direct the disposition of 1,970,000 shares of Common Stock, constituting approximately 5.6% of such class of securities; and (v) Steven A. Cohen has shared power to vote or direct the vote and shared power to dispose or direct the disposition of 2,820,200 shares of Common Stock, constituting approximately 8.0% of such class of securities. (c) Information concerning transactions in the shares of Common Stock effected by the Reporting Persons during the last 60 days is set forth in Schedule A hereto and is incorporated herein by reference. All of such transactions were effected in open market purchases through various brokerage entities on the NASDAQ exchange. (d) No person other than SAC Capital Advisors, SAC Capital Management, CR Intrinsic Investors, CR Intrinsic Investments and Steven A. Cohen is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock directly beneficially owned by SAC Associates, SAC MultiQuant and CR Intrinsic Investments. (e) Not applicable. Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. Other than as described herein, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Persons and any other person with respect to the securities of the Issuer. The Reporting Persons may, from time to time, enter into and dispose of cash-settled equity swaps or other similar derivative transactions with one or more counterparties that are based upon the value of shares of Common Stock, which transactions may be significant in amount. The profit, loss and/or return on such contracts may be wholly or partially dependent on the market value of the shares of Common Stock, the relative value of shares of Common Stock in comparison to one or more other financial instruments, indexes or securities, a basket or group of securities in which shares of Common Stock may be included, or a combination of any of the foregoing. - ------------------------- ----------------------- CUSIP NO. 06850R108 PAGE 11 OF 14 PAGES - ------------------------- ------------------------ These contracts do not give the Reporting Persons direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparties thereto to acquire, hold, vote or dispose of any securities of the Issuer. Accordingly, the Reporting Persons disclaim any beneficial ownership in any securities that may be referenced in such contracts or that may be held from time to time by any counterparties to such contracts. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. 1. Schedule A - Trading History 2. Schedule B - Joint Filing Agreement - ------------------------- ----------------------- CUSIP NO. 06850R108 PAGE 12 OF 14 PAGES - ------------------------- ------------------------ SIGNATURES After reasonable inquiry and to the best of each of the undersigned's knowledge and belief, each of the undersigned, severally and not jointly, certifies that the information set forth in this statement is true, complete and correct. Dated: July 2, 2008 S.A.C. CAPITAL ADVISORS, LLC By: /s/ Peter Nussbaum ------------------------------------------ Name: Peter Nussbaum Title: Authorized Person S.A.C. CAPITAL MANAGEMENT, LLC By: /s/ Peter Nussbaum ------------------------------------------ Name: Peter Nussbaum Title: Authorized Person CR INTRINSIC INVESTORS, LLC By: /s/ Peter Nussbaum ------------------------------------------ Name: Peter Nussbaum Title: Authorized Person CR INTRINSIC INVESTMENTS, LLC By: /s/ Peter Nussbaum ------------------------------------------ Name: Peter Nussbaum Title: Authorized Person STEVEN A. COHEN By: /s/ Peter Nussbaum ------------------------------------------ Name: Peter Nussbaum Title: Authorized Person - ------------------------- ----------------------- CUSIP NO. 06850R108 PAGE 13 OF 14 PAGES - ------------------------- ------------------------ SCHEDULE B JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13D may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. Dated: July 2, 2008 S.A.C. CAPITAL ADVISORS, LLC By: /s/ Peter Nussbaum ------------------------------- Name: Peter Nussbaum Title: Authorized Person S.A.C. CAPITAL MANAGEMENT, LLC By: /s/ Peter Nussbaum ------------------------------- Name: Peter Nussbaum Title: Authorized Person CR INTRINSIC INVESTORS, LLC By: /s/ Peter Nussbaum ------------------------------- Name: Peter Nussbaum Title: Authorized Person CR INTRINSIC INVESTMENTS, LLC By: /s/ Peter Nussbaum ------------------------------- Name: Peter Nussbaum Title: Authorized Person STEVEN A. COHEN By: /s/ Peter Nussbaum ------------------------------- Name: Peter Nussbaum Title: Authorized Person - ------------------------- ----------------------- CUSIP NO. 06850R108 PAGE 14 OF 14 PAGES - ------------------------- ------------------------ SCHEDULE A TRANSACTIONS IN THE ISSUER IN THE LAST 60 DAYS
Date Company Name Amount Price per Share ($) 5/1/2008 CR Intrinsic Investments, LLC 100 2.18 5/1/2008 CR Intrinsic Investments, LLC 1,100 2.19 5/1/2008 CR Intrinsic Investments, LLC 400 2.195 5/1/2008 CR Intrinsic Investments, LLC 9,163 2.2 5/1/2008 CR Intrinsic Investments, LLC 600 2.205 5/1/2008 CR Intrinsic Investments, LLC 3,800 2.21 5/1/2008 CR Intrinsic Investments, LLC 700 2.215 5/1/2008 CR Intrinsic Investments, LLC 2,000 2.22 5/1/2008 CR Intrinsic Investments, LLC 4,758 2.23 5/1/2008 CR Intrinsic Investments, LLC 2,084 2.24 5/1/2008 CR Intrinsic Investments, LLC 295 2.255 5/6/2008 CR Intrinsic Investments, LLC 100,000 2.03 5/6/2008 S.A.C. Capital Associates, LLC 50,000 2.03 5/6/2008 CR Intrinsic Investments, LLC 10,000 2.11 5/6/2008 CR Intrinsic Investments, LLC 2,500 2.28 5/7/2008 CR Intrinsic Investments, LLC 132 1.9 5/7/2008 CR Intrinsic Investments, LLC 100 1.905 5/7/2008 CR Intrinsic Investments, LLC 237 1.91 5/7/2008 CR Intrinsic Investments, LLC 1,000 1.915 5/7/2008 CR Intrinsic Investments, LLC 1,063 1.92 5/7/2008 CR Intrinsic Investments, LLC 500 1.93 5/7/2008 CR Intrinsic Investments, LLC 363 1.935 5/7/2008 CR Intrinsic Investments, LLC 600 1.94 5/7/2008 CR Intrinsic Investments, LLC 100 1.945 5/7/2008 CR Intrinsic Investments, LLC 10,305 1.95 5/7/2008 CR Intrinsic Investments, LLC 200 1.955 5/7/2008 CR Intrinsic Investments, LLC 700 1.96 5/7/2008 CR Intrinsic Investments, LLC 100 1.965 5/7/2008 CR Intrinsic Investments, LLC 600 1.97 5/7/2008 CR Intrinsic Investments, LLC 174 1.9725 5/7/2008 CR Intrinsic Investments, LLC 100 1.975 5/7/2008 CR Intrinsic Investments, LLC 1,800 1.98 5/7/2008 CR Intrinsic Investments, LLC 100 2.005 5/7/2008 CR Intrinsic Investments, LLC 100 2.01 5/7/2008 S.A.C. Capital Associates, LLC 2,900 2.01 5/7/2008 CR Intrinsic Investments, LLC 3,000 2.015 5/7/2008 S.A.C. Capital Associates, LLC 100 2.015 5/7/2008 CR Intrinsic Investments, LLC 28,400 2.02 5/7/2008 S.A.C. Capital Associates, LLC 32,644 2.02 5/7/2008 CR Intrinsic Investments, LLC 300 2.022 5/7/2008 S.A.C. Capital Associates, LLC 14,400 2.025 5/7/2008 S.A.C. Capital Associates, LLC 100 2.0275 5/7/2008 CR Intrinsic Investments, LLC 50,026 2.03 5/7/2008 S.A.C. Capital Associates, LLC 58,000 2.03 5/8/2008 S.A.C. Capital Associates, LLC 1,650 1.9599 5/8/2008 S.A.C. Capital Associates, LLC 400 1.96 5/8/2008 S.A.C. Capital Associates, LLC 100 1.98 5/8/2008 S.A.C. Capital Associates, LLC 100 1.985 5/8/2008 S.A.C. Capital Associates, LLC 2,000 1.99 5/8/2008 S.A.C. Capital Associates, LLC 100 1.995 5/8/2008 CR Intrinsic Investments, LLC 105,900 2 5/8/2008 S.A.C. Capital Associates, LLC 245,650 2 5/8/2008 S.A.C. Capital Associates, LLC 500 2.03 5/8/2008 S.A.C. Capital Associates, LLC 247 2.04 5/8/2008 S.A.C. Capital Associates, LLC 300 2.045 5/8/2008 S.A.C. Capital Associates, LLC 200 2.05 5/8/2008 S.A.C. Capital Associates, LLC 100 2.07 5/8/2008 S.A.C. Capital Associates, LLC 100 2.09 5/8/2008 S.A.C. Capital Associates, LLC 200 2.095 5/8/2008 S.A.C. Capital Associates, LLC 300 2.155 5/8/2008 S.A.C. Capital Associates, LLC 766 2.16 5/8/2008 S.A.C. Capital Associates, LLC 900 2.165 5/8/2008 S.A.C. Capital Associates, LLC 16,987 2.17 5/8/2008 S.A.C. Capital Associates, LLC 40,556 2.175 5/8/2008 S.A.C. Capital Associates, LLC 6,400 2.177 5/8/2008 S.A.C. Capital Associates, LLC 2,400 2.1775 5/8/2008 S.A.C. Capital Associates, LLC 7,400 2.1799 5/8/2008 S.A.C. Capital Associates, LLC 14,500 2.18 5/9/2008 CR Intrinsic Investments, LLC 100 1.895 5/9/2008 CR Intrinsic Investments, LLC 2,100 1.94 5/9/2008 S.A.C. Capital Associates, LLC 100 1.94 5/9/2008 CR Intrinsic Investments, LLC 1,400 1.95 5/9/2008 S.A.C. Capital Associates, LLC 9,400 1.9525 5/9/2008 CR Intrinsic Investments, LLC 21,001 1.955 5/9/2008 S.A.C. Capital Associates, LLC 91,025 1.955 5/9/2008 CR Intrinsic Investments, LLC 2,909 1.96 5/9/2008 S.A.C. Capital Associates, LLC 6,800 1.96 5/9/2008 CR Intrinsic Investments, LLC 100 1.962 5/9/2008 S.A.C. Capital Associates, LLC 9,300 1.962 5/9/2008 CR Intrinsic Investments, LLC 11,100 1.9625 5/9/2008 S.A.C. Capital Associates, LLC 24,700 1.9625 5/9/2008 S.A.C. Capital Associates, LLC 400 1.965 5/9/2008 CR Intrinsic Investments, LLC 900 1.9699 5/9/2008 CR Intrinsic Investments, LLC 2,700 1.97 5/9/2008 S.A.C. Capital Associates, LLC 21,475 1.97 5/9/2008 CR Intrinsic Investments, LLC 5,000 1.9799 5/9/2008 CR Intrinsic Investments, LLC 1,300 1.98 5/9/2008 S.A.C. Capital Associates, LLC 210 1.98 5/9/2008 CR Intrinsic Investments, LLC 1,500 1.9899 5/9/2008 CR Intrinsic Investments, LLC 3,324 1.99 5/9/2008 S.A.C. Capital Associates, LLC 400 1.99 5/9/2008 CR Intrinsic Investments, LLC 300 1.995 5/9/2008 S.A.C. Capital Associates, LLC 200 1.995 5/9/2008 CR Intrinsic Investments, LLC 23,162 2 5/9/2008 S.A.C. Capital Associates, LLC 40,082 2 5/9/2008 CR Intrinsic Investments, LLC 605 2.01 5/9/2008 CR Intrinsic Investments, LLC 3,800 2.04 5/9/2008 S.A.C. Capital Associates, LLC 900 2.04 5/9/2008 CR Intrinsic Investments, LLC 18,700 2.045 5/9/2008 S.A.C. Capital Associates, LLC 9,200 2.045 5/9/2008 CR Intrinsic Investments, LLC 16,100 2.05 5/9/2008 S.A.C. Capital Associates, LLC 4,100 2.05 5/9/2008 CR Intrinsic Investments, LLC 300 2.085 5/9/2008 CR Intrinsic Investments, LLC 718 2.0899 5/9/2008 S.A.C. Capital Associates, LLC 800 2.0899 5/9/2008 CR Intrinsic Investments, LLC 300 2.09 5/9/2008 S.A.C. Capital Associates, LLC 300 2.09 5/9/2008 S.A.C. Capital Associates, LLC 200 2.1 5/9/2008 CR Intrinsic Investments, LLC 300 2.11 5/9/2008 CR Intrinsic Investments, LLC 100 2.12 5/9/2008 S.A.C. Capital Associates, LLC 200 2.13 5/9/2008 CR Intrinsic Investments, LLC 200 2.14 5/9/2008 CR Intrinsic Investments, LLC 5,400 2.15 5/9/2008 CR Intrinsic Investments, LLC 500 2.1599 5/9/2008 CR Intrinsic Investments, LLC 300 2.19 5/9/2008 CR Intrinsic Investments, LLC 100 2.195 5/9/2008 CR Intrinsic Investments, LLC 100 2.2 5/9/2008 CR Intrinsic Investments, LLC 648 2.21 5/9/2008 CR Intrinsic Investments, LLC 600 2.215 5/9/2008 CR Intrinsic Investments, LLC 200 2.22 5/9/2008 S.A.C. Capital Associates, LLC 100 2.22 5/9/2008 CR Intrinsic Investments, LLC 4,000 2.225 5/9/2008 CR Intrinsic Investments, LLC 500 2.2299 5/9/2008 CR Intrinsic Investments, LLC 700 2.23 5/9/2008 S.A.C. Capital Associates, LLC 1,000 2.23 5/9/2008 CR Intrinsic Investments, LLC 300 2.235 5/9/2008 CR Intrinsic Investments, LLC 155,000 2.2355 5/9/2008 CR Intrinsic Investments, LLC 300 2.24 5/9/2008 CR Intrinsic Investments, LLC 100 2.245 5/9/2008 CR Intrinsic Investments, LLC 700 2.25 5/9/2008 S.A.C. Capital Associates, LLC 600 2.26 5/9/2008 CR Intrinsic Investments, LLC 500 2.265 5/9/2008 CR Intrinsic Investments, LLC 100 2.27 5/9/2008 S.A.C. Capital Associates, LLC 200 2.27 5/9/2008 CR Intrinsic Investments, LLC 5,600 2.28 5/9/2008 CR Intrinsic Investments, LLC 300 2.285 5/9/2008 CR Intrinsic Investments, LLC 3,200 2.29 5/9/2008 CR Intrinsic Investments, LLC 100 2.2925 5/9/2008 CR Intrinsic Investments, LLC 7,600 2.295 5/9/2008 CR Intrinsic Investments, LLC 3,700 2.2999 5/9/2008 CR Intrinsic Investments, LLC 45,223 2.3 5/9/2008 S.A.C. Capital Associates, LLC 2,708 2.3 5/9/2008 CR Intrinsic Investments, LLC 3,800 2.31 5/9/2008 S.A.C. Capital Associates, LLC 6,900 2.31 5/9/2008 S.A.C. Capital Associates, LLC 4,800 2.32 5/9/2008 CR Intrinsic Investments, LLC 1,500 2.33 5/9/2008 S.A.C. Capital Associates, LLC 1,900 2.33 5/9/2008 S.A.C. Capital Associates, LLC 100 2.34 5/9/2008 S.A.C. Capital Associates, LLC 2,295 2.35 5/9/2008 S.A.C. Capital Associates, LLC 200 2.36 5/9/2008 S.A.C. Capital Associates, LLC 2,008 2.37 5/9/2008 S.A.C. Capital Associates, LLC 1,800 2.38 5/9/2008 S.A.C. Capital Associates, LLC 2,200 2.39 5/9/2008 S.A.C. Capital Associates, LLC 3,397 2.4 5/12/2008 S.A.C. MultiQuant Fund, LLC (200) 2.33 5/13/2008 CR Intrinsic Investments, LLC 100 2.13 5/13/2008 CR Intrinsic Investments, LLC 800 2.14 5/13/2008 CR Intrinsic Investments, LLC 100 2.15 5/13/2008 CR Intrinsic Investments, LLC 3,105 2.16 5/13/2008 CR Intrinsic Investments, LLC 100 2.18 5/13/2008 S.A.C. MultiQuant Fund, LLC 100 2.23 5/13/2008 CR Intrinsic Investments, LLC 400 2.25 5/13/2008 S.A.C. MultiQuant Fund, LLC 100 2.26 5/13/2008 CR Intrinsic Investments, LLC 2,100 2.29 5/13/2008 CR Intrinsic Investments, LLC 3,295 2.33 5/15/2008 CR Intrinsic Investments, LLC 1,100 2.1 5/15/2008 CR Intrinsic Investments, LLC 1,681 2.12 5/15/2008 CR Intrinsic Investments, LLC 10,200 2.13 5/15/2008 CR Intrinsic Investments, LLC 100 2.15 5/15/2008 CR Intrinsic Investments, LLC 6,200 2.21 5/15/2008 CR Intrinsic Investments, LLC 8,601 2.22 5/15/2008 CR Intrinsic Investments, LLC 400 2.23 5/15/2008 CR Intrinsic Investments, LLC 700 2.27 5/16/2008 CR Intrinsic Investments, LLC 10,000 2.27 5/30/2008 CR Intrinsic Investments, LLC 600 2.36 5/30/2008 CR Intrinsic Investments, LLC 700 2.38 5/30/2008 CR Intrinsic Investments, LLC 100 2.39 5/30/2008 CR Intrinsic Investments, LLC 3,100 2.44 5/30/2008 CR Intrinsic Investments, LLC 2,000 2.48 5/30/2008 CR Intrinsic Investments, LLC 10,000 2.49 5/30/2008 CR Intrinsic Investments, LLC 16,700 2.5 5/30/2008 CR Intrinsic Investments, LLC 16,800 2.51 6/13/2008 CR Intrinsic Investments, LLC 1,500 2.18 6/13/2008 CR Intrinsic Investments, LLC 400 2.19 6/13/2008 CR Intrinsic Investments, LLC 43,700 2.2 6/23/2008 CR Intrinsic Investments, LLC 273,213 4.04 6/23/2008 S.A.C. Capital Associates, LLC 150,000 4.04 6/23/2008 CR Intrinsic Investments, LLC 126,805 4.05 6/23/2008 S.A.C. Capital Associates, LLC (50,000) 4.05 6/26/2008 S.A.C. MultiQuant Fund, LLC (200) 4.02 7/1/2008 S.A.C. MultiQuant Fund, LLC 200 4.025 7/1/2008 S.A.C. MultiQuant Fund, LLC 200 4.025
-----END PRIVACY-ENHANCED MESSAGE-----